Research Output per year
Personal profile
Ancillary activities
- FFUND BV | Amsterdam | Directeur/eigenaar | 2016-10-19 - present
- Triall BV | Maarssen | Partner | 2018-05-07 - present
- Phemke BV | Zeist | Partner | 2018-12-31 - present
- Sovalacc BV | Rotterdam | Directeur/eigenaar | 2019-02-01 - present
Ancillary activities are updated daily
Fingerprint Dive into the research topics where Linda van de Burgwal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 4 Similar Profiles
Probiotics
Medicine & Life Sciences
probiotics
Agriculture & Biology
Practice Guidelines
Medicine & Life Sciences
Root Cause Analysis
Medicine & Life Sciences
Public-Private Sector Partnerships
Medicine & Life Sciences
Information Dissemination
Medicine & Life Sciences
stakeholders
Agriculture & Biology
Research
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2009 2019
Aiming for impact: Differential effect of motivational drivers on effort and performance in knowledge valorisation
van de Burgwal, L., Hendrikse, R. & Claassen, H. J. H. M., 29 May 2019, In : Science and Public Policy.Research output: Contribution to Journal › Article › Academic › peer-review
Open Access
civil society
driver
economics
performance
stakeholder
Overcoming challenges for designing and implementing the One Health approach: A systematic review of the literature
dos S. Ribeiro, C., van de Burgwal, L. H. M. & Regeer, B. J., 1 Jun 2019, In : One Health. 7, 100085.Research output: Contribution to Journal › Review article › Academic › peer-review
Global Health
Education
Health
Probiotics for improving quality of life in ulcerative colitis: Exploring the patient perspective
van der Waal, M. B., Flach, J., Browne, P. D., Besseling-van der Vaart, I., Claassen, E. & van de Burgwal, L. H. M., Mar 2019, In : PharmaNutrition. 7, p. 1-14 14 p., 100139.Research output: Contribution to Journal › Article › Academic › peer-review
colitis
Probiotics
quality of life
Ulcerative Colitis
probiotics
The Nagoya Protocol on Access to Genetic Resources and Benefit Sharing: Best practices for users of Lactic Acid Bacteria
Flach, J., dos S. Ribeiro, C., van der Waal, M. B., van der Waal, R. X., Claassen, E. & van de Burgwal, L. H. M., Sep 2019, In : PharmaNutrition. 9, p. 1-6 6 p., 100158.Research output: Contribution to Journal › Article › Academic › peer-review
Open Access
genetic resources
Practice Guidelines
lactic acid bacteria
Lactic Acid
Bacteria
Accelerating microbiota product development: The Societal Impact Value Cycle as a conceptual model to shape and improve public-private valorization processes
Van de Burgwal, L. H. M., Van der Waal, M. B. & Claassen, E., Dec 2018, In : PharmaNutrition. 6, 4, p. 157-168 12 p.Research output: Contribution to Journal › Review article › Academic › peer-review
Open Access
product development
Microbiota
Probiotics
Industry
Public-Private Sector Partnerships
Activities 2017 2017
- 1 Lecture / Presentation
Valorisation in Practice
Linda van de Burgwal (Speaker)25 Mar 2017
Activity: Lecture / Presentation › Academic